 |
FDA agrees to study Botox rivalFrench drugs group Ipsen and its US partner Medicis said the Food and Drug Administration had agreed to consider the US marketing of Reloxin in a potential boost for the would-be Botox competitor. The two companies filed an application in More… |
Monday 20 May 2024
